Prior to joining Cynvec, Mr Stonebanks led the global healthcare and life science mergers and acquisitions efforts at IBM, advising the company on its healthcare and life science strategy.
Mr Stonebanks has completed his undergraduate degree in Exercise Physiology at the University of Victoria, British Columbia, Canada and his MBA in pharmaceutical marketing at St Joseph’s University in Philadelphia.
Steve Blumenthal, chairman of the board at Cynvec, said: “Frank brings a remarkably consistent track record of accomplishment in building start-ups into successful companies. He is a proven leader who will serve as the foundation of our management team to advance our promising preclinical compounds into the clinic.”